Related Experiment Video
Updated: Mar 24, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.8K
Mirtazapine: only for depression?
11Department of Psychiatry, Hospital de San Rafael, Barcelona, Spain.
Acta Neuropsychiatrica
|March 19, 2016
Summary
Mirtazapine, an antidepressant, shows potential for treating various conditions beyond major depression. Further research is needed to confirm its effectiveness in these off-label uses.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Mirtazapine, approved in 1994, is primarily used for major depressive disorder.
- Emerging evidence suggests efficacy in diverse psychiatric and medical conditions.
Purpose of the Study:
- To review existing literature on the off-label indications of Mirtazapine.
- To identify conditions where Mirtazapine has been explored beyond its primary indication.
Main Methods:
- Comprehensive literature search of MEDLINE, PsycLIT, and EMBASE databases up to March 2006.
- Inclusion criteria focused on studies of Mirtazapine for conditions other than major depression.
- Keywords included mirtazapine, case-reports, open-label trials, and randomized controlled trials.
Main Results:
- Off-label Mirtazapine use reported for anxiety disorders (panic, GAD, social phobia, OCD), PTSD, dysthymia, and various depression subtypes (menopausal, poststroke, HIV-associated, elderly, MDMA-induced).
- Investigated for non-psychiatric conditions including hot flashes, substance use disorders, sleep disorders, sexual dysfunction, headaches, cancer pain, fibromyalgia, and schizophrenia.
- A wide array of conditions show preliminary evidence for Mirtazapine's off-label utility.
Conclusions:
- Current data on Mirtazapine's off-label efficacy are primarily from case reports and open-label studies.
- Preliminary findings suggest Mirtazapine's potential in numerous disorders.
- Randomized controlled trials are necessary to validate these preliminary results and support broader clinical use.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.0K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.0K
01:26Psychosis: Goals of Pharmacotherapy
660
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
660
01:25Antidepressant Drugs: Overview
1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
01:24Mania and Antimanic Drugs: Overview
756
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
756
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
805
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
805